These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1277714)

  • 1. Intestinal absorption, demethylation, and enterohepatic circulation of imipramine.
    Dencker H; Dencker SJ; Green A; Nagy A
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):584-6. PubMed ID: 1277714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable isotope coadministration methodology for the estimation of the fraction of imipramine metabolized to desipramine.
    Sasaki Y; Shinohara Y; Baba S
    J Pharm Sci; 1990 Feb; 79(2):96-8. PubMed ID: 2324970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the origin of desmethyl imipramine in rat brain.
    Roubein IF; Keup W
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):633-40. PubMed ID: 1153843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cimetidine and ranitidine on imipramine demethylation and desmethylimipramine hydroxylation by human liver microsomes.
    Spina E; Koike Y
    Eur J Clin Pharmacol; 1986; 30(2):239-42. PubMed ID: 3709653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-pass metabolism of imipramine in man.
    Gram LF; Christiansen J
    Clin Pharmacol Ther; 1975 May; 17(5):555-63. PubMed ID: 1126113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study.
    Melzacka M; Danek L; Adamus A
    Pol J Pharmacol Pharm; 1987; 39(4):379-86. PubMed ID: 3449809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prolonged administration of imipramine on its hepatic metabolism in rats.
    Daniel W; Melzacka M
    Pol J Pharmacol Pharm; 1987; 39(2):135-41. PubMed ID: 3432159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain.
    Daniel W; Melzacka M
    Biochem Pharmacol; 1986 Oct; 35(19):3249-53. PubMed ID: 2876708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic interconversions and binding of imipramine, imipramine-N-oxide, and desmethylimipramine in rat liver slices.
    Bickel MH; Gigon PL
    Xenobiotica; 1971 Nov; 1(6):631-41. PubMed ID: 4154539
    [No Abstract]   [Full Text] [Related]  

  • 13. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species and dose differences in the accumulation of imipramine by mammalian lungs.
    Drew R; Siddik ZH; Mimnaugh EG; Gram TE
    Drug Metab Dispos; 1981; 9(4):322-6. PubMed ID: 6114830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
    Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype.
    Brøsen K; Otton SV; Gram LF
    Clin Pharmacol Ther; 1986 Nov; 40(5):543-9. PubMed ID: 3769385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental imipramine and desipramine poisoning in the rat.
    Rauws AG; Olling M
    Arch Toxicol; 1976 Mar; 35(2):97-106. PubMed ID: 947318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL; Simpkins JW; Stout SA
    Psychopharmacology (Berl); 1984; 84(2):225-30. PubMed ID: 6438681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.